In 2,000, the Colorectal Working Group of the American Joint Committee on Cancer (AJCC) even proposed the inclusion of serum level of CEA (C-stage) into conventional TNM staging of rectal cancer (27). The gene discussed is CEACAM5; the disease is rectal cancer.